Hello, everyone, and welcome to the Solar Foods go-to-market update. My name is Maria Rämö, and I am here today with our CEO, Rami Jokela, and CFO and Deputy CEO, Ilkka Saura. Also with us today is, from Fazer, Heli Anttila, Vice President, Product Research and Development. It has been an exciting day for Solar Foods. We will first talk about the new chapter about to begin for Solein in Europe.
We will present a market update and discuss our go-to-market strategy. Heli will be talking about Fazer's plans in commercializing Solein. You in the audience have the possibility to ask questions in the chat function throughout the webcast, and at the end of the presentation, we will have a Q&A session. Let's get going. Rami, please.
Yeah. Thank you, Maria. This is absolutely the day what we have been waiting a long time. So, what has happened? The news today represents a significant milestone in Solar Foods' whole history. The European Food Safety Authority, EFSA, have completed scientific safety assessment positively and concluded that Solein, our product, is safe under the proposed condition of use. This is absolutely great news.
You can feel it perhaps from me already that how excited I am, but we have been waiting this a long time. This is not only good news for Solar Foods, but especially for customers and consumers in Europe. EFSA is the golden standard. EFSA's scientific assessment is widely regarded as one of the most extensive and thorough food safety review globally.
The positive opinion, what we have now achieved, can therefore provide a strong reference point for other markets, especially where the equivalent novel food assessment framework may not be existing today. We are absolutely happy as a reference point as well. The assessment itself took quite a long time. We started with our application 2021, already five years ago.
But we are very happy because EFSA have conducted extensive scientific safety assessment covering the product, manufacturing process, and consumer safety assessments supported by our detailed information and scientific evidence what we have provided in a good collaboration. We are very happy, even it took a very long time, but it is a golden standard, and now we have achieved this positive opinion. Let's celebrate a little bit when it is already the time, but now what is the next step?
Next step, the European Commission will now prepare the draft implementing act, present it to the relevant Member States committee for the vote, and formally adopt the act. We estimate that this process will take approximately seven to nine months based on the similar novel food ingredient EU authorization. We in Solar Foods, we are very confident that the vote result will support EFSA's positive scientific opinion, which was published today.
There is also other reason why today is a significant day for Solar Foods. We are the first company in the world to receive the positive EFSA opinion for the novel food ingredient produced through the gas fermentation technology. Why so? Gas fermentation technology enables to produce big volumes, such as food, the most economic and cost-efficient way among any other fermentation technologies.
We see that this could enable really the huge volumes of the food proteins to be produced at affordable prices for the consumers. Let's look what EFSA's positive opinion really means to us now. What will change? After the EFSA's positive scientific opinion, we expect EU authorization next year, 2027. The process will take, like I said, seven to nine months based on our estimation.
This will continue to accelerate all our commercial negotiations in Europe now, already now, because everybody have been waiting for this scientific opinion, which is positive. All the launch plans what are coming typically, it takes also a long time, so I really see that this will accelerate all these negotiations, discussions, which countries, which companies, which products we are going to launch. The scientific opinion is also absolutely key for our binding offtake negotiations for the Factory 02.
This is going to continue and accelerate. Many of our customers have been waiting for this one. This is a key milestone really to continue the negotiations as well to accelerate many more. This is also doubling our addressable market. If you combine the U.S., we actually have been already some time, and as well the Singapore, but now the Europe is one of the major markets. We are doubling our addressable market now, what Ilkka Saura later will tell more about. This is also our home market.
Of course, we want to be present in our home market. Our consumers can enjoy the Solein-based products. Finally, if I put what is the key for especially me as a CEO, the key uncertainty in the Factory 02 financing plans and also limit these offtakes which are linked with that one, they are absolutely reduced.
This risk, what was there perhaps, what's going to happen, so it's absolutely reduced, this uncertainty. This is very good. That supports our preparations now for our final investment decisions path towards the F02 factory. One information about why the Solein demand and also protein demand as such overall is so big. We have been already earlier this half-year updates explained about the protein megatrend like we did in H1 update a few months back.
Now the McKinsey have updated what is the consumer wellness market, and it's already $2.7 trillion. It's more than 20% more what was two years ago. Really, it's accelerating. There seems to be more momentum coming and more demand coming as well. There's a challenge in the supply with the high-quality proteins. Why is that?
Consumers are seeking healthier lifestyles, and they are looking actually really what is the content list of the proteins, how good complete proteins those are. Proteins start to be everywhere, every food categories, breakfast, coffees, all these other areas as well, what typically was perhaps in the past only the sports people.
The third one, it's also the weight loss drugs driving the demand. The GLP-1 users typically doubling the protein intake daily as well. Typically, if you have a normal person, a little bit less than one gram per kilo per day, so it can go up to 1.6 grams per kilo per day if you are the GLP-1 user in order to have the quality protein and support the whole your body systems, muscles, and so on. Big picture.
As CEO of Solar Foods, I see that this is a significant day also thinking about how we can help the whole world, Europe, but also the whole world in this, because EFSA is the golden standard, like I said. United Nations have indicated that we need 60% more food production to feed the people by 2050. Same time, United Nations have indicated that there will be 25% less food production due to the climate change, water scarcity, and soil degradation.
You can see that there is a mismatch. More need needed, and same time, less will be available. Why is that? Global warming is affecting the food prices. Agricultural land and availability, already 43% is used for the land for the agriculture. There is no good land more available in the world for that one.
El Niño this year absolutely affected the food prices, and we will see the next two years this impact. It can be up to the 16% increase in the ingredient prices. This is the highest ever impact what we have understood in the past. Fertilizer prices have instability, so we have seen that some of the prices have doubled.
Perhaps very interesting is also that there is a decreasing dairy production output because of the very extreme heat conditions and because those will affect how much milk you will get from the cows and milking cows as such. That's why many of the countries and regions, they are looking for this food sovereignty. They are seeing how we can actually have stable, affordable prices, quality, and supply.
Solar Foods, we have got contact more than 40 different countries to establish the factories in order to actually support the security of food or food sovereignty as such. This is absolutely because of those what I said. There's more need of the food, and there's expected to be less food production due to this climate change for the scarcity, degradation of the soil.
All right. Next we go to market update. Before to go to market update, I like to little bit tell so how we have been working with our customers in the past. We have set up the core team leading all the negotiations with our leading customers, offtake customers especially, and market launches. This has been led by me, our CCPO, Godert Zijlstra, and also our CFO, Deputy CEO, Ilkka Saura.
We have been a team of three plus all the commercial product people and regulatory people. We have been working with our customers continuously and solving actually how we can get this our value proposition working, application development, and at the end, launch plans and what are the offtakes and term sheets as such. That's why with the latest news as well that Ilkka, you as a Deputy CEO is taking care of this whole our company commercial traction. I'm very happy to hand over to you, and you tell about the market and what this means to the commercial point of view for Solar Foods.
Thank you so much, Rami. Ilkka Saura, CFO and Deputy CEO of the company. Very pleased to be here with you today and taking an overview on the markets. This indeed adds a significant new element on the addressable market. We are also taking a look on what is happening on the markets and what is our go-to-market strategy as we move on with the commercialization of Solein.
We are very glad to discuss EU market, our home turf, which is now opening for us through this EFSA's opinion with the EU approval looming in the horizon, but also a wider view what is happening. Indeed, we are seeing a major market shift. Protein is no longer just a sports nutrition high-end ingredient. It is becoming a mainstream and moving into everyday foods and on all of our plates that we continue to eat.
Our focus is indeed in this larger addressable market, solving traditional protein challenges, which are gaining more ground as well as meeting these demand drivers, which are somewhat interesting as we speak, and providing us quite a bit of tailwind. The core theme around these markets and functional foods, which we introduce today, is nutrient density.
It's not only about protein, it's also about fibers and other nutritional values in which Solein indeed excels quite a bit. Let's take a view on how the addressable market is developing. Like I said, indeed we see a structural shift in nutrition, which is impacted by a number of drivers, which Rami also explained. People are seeking and shifting towards active lifestyles.
They discuss about healthy aging and better metabolic health, meaning that protein demand globally is growing, meaning that protein moves into mainstream foods and applications, requiring taste and functionality a lot more than before, in which consumers are not willing to do compromises. Solein, as an ingredient and with its inherent characteristics, is becoming increasingly relevant from commercial angle because of its superior characteristics in taste, texture, nutritional values, and so forth.
We opened a new category as part of the market called functional foods. We originally have looked Solein primarily to the lens of high-performance sports nutrition market. What we now see is much broader. Protein is becoming an everyday consumer benefit that significantly expands number of applications where Solein can add value.
European Union and EU market, yes, indeed, it represents a significant commercial opportunity for Solar Foods alongside the United States, where the company has already been commercializing Solein for two years, and where we also have quite nice results. The total addressable market for Solein in the European Union is expected to hit EUR 7 billion by 2030, second-largest protein market in the world.
In terms of the numbers, by 2030, this combined addressable market will reach around EUR 18 billion, of which Europe itself accounts for about EUR 7 billion, meaning about 8% compound annual growth rate from 2025 to 2030. Absolutely an interesting market, and our focus in this market will remain in strategic categories in the premium segments and customers and partnerships which are focusing on functionality and differentiation, which matter the most for our customers.
Solein, now deemed safe in Europe, it indeed provides steady supply, consistent quality, and predictable economics for our customers. These are the key building blocks for the success in the combined market, which I just presented. Controlled production supports consistent year-round output, providing the customers the opportunity to base their business models and growth projections on this business. Value propositions remain superior.
Like I said, nutritional values, functionality, resilience, and sustainability remain in the core of this ingredient. What is happening in the markets at the moment, and while we benchmark ourselves, we typically take the benchmark way, the animal-based protein, which is leading the market as we speak. Over FY 2026 this year, we have seen unprecedented volatility in the prices, and also last year.
What the market is expecting from our peer group and global CPGs and protein suppliers is that they basically expect that food manufacturers reduce WPC and WPI, whey isolate and concentrate content, and reformulate the products towards alternatives because of the high input costs. This has actually led into the elevated price points of these alternatives, which is we are seeing what comes to milk protein concentrates, for example.
Of course, alternative protein substitutes and ingredients are coming to the markets, which may have disadvantages in solubility, taste, and texture. Solein, as an ingredient, offers durable opportunity for these customers and their consumers through reformulation based on functionality, economics, and supply independence. I would like to also highlight that regardless of this unprecedented volatility and high prices, our business case and investment case on the long-term horizon is not dependent on these ingredients pricing at all.
A little bit of what we see in the European markets. A nice snapshot what has been happening over the past four years is shown here. So, protein everywhere. Like I said, protein is coming into every single category and application almost, and this is becoming an industry-wide shift, not just a consumer frenzy and a short-term trend.
The most fast-growing launch categories actually have been bars, ready-to-drink beverages, and protein ice creams, in which the company, Solar Foods, has been investing heavily over the past years. We have basically, as we say, hit the nail in the selections of these categories in 2024 strategy update as part of the capital market days in December. We see that the competitive landscape provides us quite a bit of tailwind.
We see, of course, these launches, but on top of this, major food companies are committing more and more R&D resources, bringing more capacity on stream, as well as committing interesting M&A transactions in the field. These launches, referring to them again, show commitment to this experimentation and exactly underline the fact that consumer trends and willingness to try these are increasing.
Not necessarily sell-through or repeat purchase might be on their agenda while they move on. We, of course, expect that some products may fail. Protein washing is indeed a trend which is kind of underscoring and underlined in the markets at the moment, but we believe with this ingredient, customers can really add more value. On a global perspective and wider perspective on these categories and how Solein behaves is that Solein really offers the unique value proposition in other categories as well.
Through multi-year collaboration with our customers, Solein indeed excels in a number of these key categories, such as RTDs, ice cream, baked goods, and bars, and ready-to-mix shakes, by the way. We see that Solein, like I said, offers the durable opportunity for the customers through reformulation. It is a very versatile ingredient.
We have somewhat strong results in UHT-treated products like ready-to-drink, developed with our partners over the multi-year development journeys. We also are seeing somewhat interesting heat durability and improved extrusion capabilities, and also improving the digestibility of the ingredient, which is at the very core of these ingredients. I want to underscore the meaning and importance of clean labeling.
Alongside this nutrient density, it is becoming more and more important to have clean label and less processed foods for the end consumers, which might also challenge these protein-fortified products based on animal ingredients. I want to take an example from first half of this year and over the summer, which continued to the second half of the year, the launch with Ambrosia Collective, which came online in May this year.
It has basically become their bestseller in their online platform and in their online channels, in Amazon and their own website. We are expecting to see more and more flavors. Recently, they announced the melty chocolate flavor and are, together with us, aiming for a U.S.-wide distribution with this product. So, a lot of interesting stuff in the pipeline, meaning that our investment in the product is really starting to pay off.
Of course, I want to make a notion on a very important theme in the food markets at the moment. It is GLP-1, which Rami already introduced. We want to highlight a couple of key parameters. It is, of course, that people, like we said, are shifting towards the healthier lifestyles, and it also goes through medication. GLP-1, for us, it means greater nutrient density per calorie, which Solein has.
We see that protecting muscle mass during weight loss is becoming more and more vital, and on top of the high protein content, patients under GLP-1 are looking more and more fibers and fiber intake on a daily basis. I want to highlight that, of course, Solein fiber content, about 40% of that is beta-glucans, which is having a super strong value proposition in the GLP-1 space. A little bit about the numbers.
We are going to see a massive shift towards higher intake and penetration of GLP-1 treatments. By 2030, we are expecting about 70 million consumers combining Europe and U.S. being under GLP-1 in the adult population. This could actually mean a potential incremental increase in protein demand of about 250 kilotons per year. So, introducing a massive opportunity for Solar Foods.
I want to highlight that whenever people shift towards the GLP-1, the data, market data publicly available shows that three main categories are seeing more and more volumes. Those being yogurt and yogurt drinks, meat snacks, and nutrition bars, including protein bars, in which the company, by the way, has invested quite a bit over the years, and first products are going to be seen relatively soon. All right. A little bit about our go-to-market strategy and what is happening next.
Like I said, the go-to-market strategy technically remains the same. As you know, we have been focusing on a quick go-to-market with fast-moving agile health and performance companies, especially in the U.S. and Europe, and also focusing on the large CPGs, on the partnerships, and long-term demand for Factory 02 volumes, which we have had quite interesting results already.
Now, we add another market, European Union, under it, regulatory risks substantially reduced, customer discussions are advancing, and commercial preparations are now to accelerate towards the final investment decision of the next factory. A little bit more about the European Union and go-to-market activities. We continue to target CPGs, food ingredient distributors, and health and performance brands, as well as selected fast movers. We continue to build initial sales pipeline and expect the first launch of this product next year.
Several major food brands in Europe and health and performance brands are now clear to go in their concept and recipe development, and most likely are going to launch some launch plans in more details as we move on with this plan. But now, one of these partners and customers that have been as a shareholder also with us on board for many years is now here today with us.
Fazer Group, a very well-established Finnish Nordic CPG company, is now here today with us, and their representative, Heli Anttila, Vice President, Product Development, Innovation, and Public Affairs, is today with us. Heli, please, you already joined the stage. Welcome again, and over to you.
Thank you very much. It's happy to be here, and congratulations about the really significant milestone in the journey. So, a few words about how do we prepare the launch of Solein to the consumer products in Europe. The decision made this decade will have a long-lasting impact to our future. At Fazer, our mission is to create food with a purpose. We aim to create long-term value while mitigating the climate change and operating within the planetary boundaries.
At the same time, consumers are looking for products that support their health, well-being, and more sustainable lifestyles. Meeting these challenges requires new innovations, new sources of nutritions, and new products for the consumers. This is why Fazer and Solar Foods entered into the strategic partnership in 2019. Together, we have been developing and commercializing Solein and novel protein ingredients that can complement existing protein solutions for the consumers.
Fazer is one of the Solar Foods' first commercial partners, its largest shareholder, and has been also involved in the development of the Finnish pioneering innovations from the very beginning. The partnerships combines expertise in R&D, innovation, commercialization to help to shape the more sustainable food systems for the future. Fazer has been the first company in the world to bring Solein into the packed consumer products.
So, we have discussed together already the idea in 2021. Then the Singapore pilot was launched when the Singapore novel food approvals was claimed in 2023 under the Taste the Future concept, and it's an umbrella concept while we are piloting the prototyping and branding alternatives for the new novel ingredients for the consumers. Then Solar Foods got the U.S. approval for the Solein protein. We pilot it in U.S. 2025, combining Fazer chocolate and oat expertise with the Solein protein.
We are approaching the EU Commission approval in the next year, so we are preparing the readiness to launch in Europe. Key learnings from these pilots, we do the pilots that we do learn from the consumers about the novel ingredient and about the new innovations. It needs to be easy to understand, so the communication is key for the consumers. People tend to expect that the product tastes a little bit weird or something different if they do not fully understand what it is. It is important that it is part of the familiar product format that is really then easier for consumer to test and also then to take it into their daily use.
Taste is always a key when we talk about the food products, and it is also when it is a familiar product and great tasting, they are really interested about the product. The feedback what we got was in the first pilot that, it feels a little bit weird that it is food from the out of the thin air, but then they realized then that they really love the product, that the taste is excellent and good.
They also thought that it is a really innovative product, is it really good? But then when they taste it, they saw that it is extremely good. A lot of questions that when it is available after the pilots. That is then coming next. We are preparing to launch Solein consumer products in Europe.
We are ready to bring the Solein-containing consumer products to the European market once then the final approval is granted by the European Commission. As we heard earlier, interest in the protein continues to increase, and our aim is to make this high-protein innovation easily available for the consumers by bringing the Solein into the familiar product types and product solutions.
Solein brings something very ingeniously new into the already crowded protein category, and I think successful commercialization is then key, bringing the innovations like Solein to the larger audience and creating a real impact for the consumers. This is the plan, and thank you very much for the great cooperation with the Solar Foods team, and congratulations about the significant milestone.
Thank you, Heli.
Yeah, likewise. Heli, thank you for absolutely great collaboration. Without the owner, because the shareholder of the company as well actually could collaborate in R&D, this would be not possible. Let's make a good plan, successful launches after the European authorization is there. All right, so I will now summarize this significant day, what we have today. What it actually it is, to you to understand. Before we go, actually, perhaps why to invest in Solar Foods now.
If we take a step back, I mentioned about the United Nations, that there is a challenge at the moment to produce the food in 2050 or next coming years, enough nutritious food to all people in the planet. I also commented that there's different solutions. Agriculture, you can go perhaps more the digital AI and try to do it better, but land is no more.
It's very, very limited what you can do. Based on the all the analysis, it's seen now by multiple countries that the fermentation technology is the leading technology enabled to decouple from the agriculture, the food production. Gas fermentation, what I mentioned, is the leading technology to make it big volumes, the affordable prices as well.
Today, in gas fermentation for the food production, there's only one company who have permissions to sell any country today, Singapore and U.S. It's Solar Foods. Now, we are really in a journey to start towards the Europe and make Europe consumers and customers together successful after the European authorities' approval finally, that this is possible in Europe as well. So, we have more than 200 patents for supporting our gas fermentation process. We are the leading pioneering technology company for that one.
Where we are today, we are commercialization and scaling, and we are absolutely able to scale with our partners, with our go-to-market partners, CPG companies, health and performance companies, also the building the factory with our technology partners as well. So, everything is there waiting perhaps this moment that our home market is finally soon expected to open.
All right, so this is a big picture, perhaps just one more time what we typically like to say, why to invest Solar Foods? In the megatrends, we are in the sweet spot and only company connecting megatrend of the protein, food sovereignty, as well as the energy transition, where we are using hydrogen as one of the key raw materials to get the CO2. What means in now near term? So, perhaps you are interested for this, what is a slide here.
This positive EFSA opinion, it will advance all our negotiations with our customers, what actually has been perhaps waiting for this. Is this now happening here for our customers or not? Now, you already heard that we doubled our addressable market. So, we get more supporting legs, and two main markets, which are now the U.S. and Europe, expected to support our business.
This is absolutely great as a CEO, the behalf of the Solar Foods, to say that, yeah, this is a good future. Number 2, you heard already about unique value propositions. Over these years, we have been working with our customers and collaboration partner like Fazer, what you heard, and this is giving the feedback for us what works, what don't work, and how actually we take the next generation of Solein for our consumers as well.
We are absolutely great in this kind of protein, how good quality protein. We also have fibers, like Ilkka Saura was explaining, and of course, we have this kind of very good minerals and vitamins as well. U.S. and Singapore, you already can find Solein-based products. We are really counting the days or months now that next year, summertime, if you go according our expectations, everything goes well.
We are launching that together with our partner, Fazer, here as well. I believe there will be many more customers who are eager to work with us as well. Big launches you can expect. You saw the whole map earlier that Europe is expected to be open. This is the key milestone. EFSA scientific opinion is key milestone for the food safety.
Then if we go number 4, this is enabling and de-risking all our financial plans and how we collect the final part of the funding for our Factory 02 project. Of course, the offtakes which we need in order to make the final investment decision. This is absolutely key. Then you can see it took a little bit longer time with EFSA than what we expected, so more than five years.
Of course, we adjust all our plans now. This is now the continue accelerating this. Of course, we review now how this FID, final investment decision for the Factory 02, how the negotiations with the offtake customers in Europe as well will continue now as well. That's the key moment. If I summarize, today happened three things. Solein is seen safe in Europe by the EFSA Food Authority.
We doubled our market, which is very good actually for our business, and also the de-risking this that we get enough offtakes for Factory 02. Number 3, now really we accelerate our negotiations with our customers and our offtakers for Factory 02. I'm very, very happy for the day because not only me and Ilkka and Heli, you and Maria, you have been waiting for this.
I know that there's been heavy hard work multiple years by our regulatory first team, as well all our partners supporting that as well, and the whole Solar Foods actually to make this day happen. We end up very positive news, and I'm very, very happy and thank you for that one. Looking forward for what more we can do together now with our partners with this new information. Next, I think we go Q&A. Maria, what about if you will come back here and we start to take some questions?
Yes, thank you. We have received a couple of kind messages saying congratulations, so thank you very much for those. Rami, let's start with you. Can you tell more about the novel food regulatory process in the EU? What makes this opinion a major milestone for the company?
Perhaps I refer a little bit what I explained. EFSA is seen golden standard globally of any of those scientific safety assessments. So, when EFSA will now, the outcome was a positive news. So, of course, this is in Europe very good. We can accelerate all our negotiations with customers and towards the final investment decision. It will also help the other next countries.
So, there is a lot of countries which are following what EFSA decides, because they know that EFSA is a very extensive, thorough analysis, and we need to have scientific evidence that this is safe as a product, production process, and consumers intake, daily intake, what the category is, what we have applied. So, this is a major milestone for us. And especially, I am glad that the European consumers and our home market, they can, I hope, very soon enjoy the Solein-based products.
Thank you, Rami. Ilkka, are you expecting new companies to join Factory 02 offtake negotiations now that you received the positive EFSA opinion? Or should we assume you to progress for now solely with the ones already under LOIs?
Yeah. If we take a perspective, for example, of a European health and performance brand, their progress in bringing Solein as one of their ingredients in the product range has been somewhat basically constrained because of this regulatory progress. Today showed that yes, indeed, in certain selective strategic categories, this will become, as per company's expectations, possible in the very close foreseeable future.
Feedback what we have received from these kind of customers is some are willing to progress and have been willing to progress regardless of the status, but now we expect acceleration in the pipeline, also in terms of new logos, but also accelerating the existing ones towards the binding deals.
Thank you, Ilkka. Another question for you.
Go ahead.
You mentioned in the press release that EFSA opinion means Solein is safe to use as a protein ingredient in selected strategic food categories. How broad are these selected strategic food categories? Is there reason to assume Solein's allowed applications being more narrow at first in Europe and broadening later on?
Yeah. So indeed, this safety assessment is based on somewhat wide and extensive statistical analysis on different intake of food categories across age groups. And the assessment has been completed, and the categories which are included in the statistical datasets and part of EFSA's assessment are there. However, I want to highlight that the categories will be finally approved by European Commission and remains to be worked on by the company and commission itself.
So, the ones that we've said and have been mentioned in the opinion are not final necessarily, and are something that we continue to evaluate. The focus on the categories will certainly be the categories which we have said publicly. So, health and performance, the fastest growing categories like bars, drinks, protein ice creams, stuff like that. And remains to be seen what are the final categories, and we will certainly keep you updated about that.
Thank you, Ilkka. Then a couple of questions about Factory 02 for Rami. Does the EFSA conclusion have any importance for the Lappeenranta factory investment decision, and does Solar Foods still aim to make the final investment decision on Factory 02 in 2026?
This is a huge impact. Many of our European customers, we have been working multiple years. You heard already, Fazer have been many years working together with us. There are other big companies as well, especially in the middle Europe. It's like Ilkka Saura said, some have been proactive and lean forward, and they said that we will get someday this EFSA scientific opinion, positive opinion.
They do not want to lose any months for the launches, and perhaps helping their supply chain and price points and quality as well, like we commented. This is now de-risking, unlocking this situation, especially with the European customers. Now I see that together with our team and Ilkka and few more, that we can accelerate the discussions.
We have been paused and waiting the moment already quite a few months, to be frank. Now those are accelerating. With those discussions, we will get enough offtakes. Of course, the U.S. market is open. We have a similar discussion over there. Then we have enough for ensuring the funding, what we are needing with the terms, what are multi-year terms, of course.
That will be leading us to the final investment decision of the Factory 02. I'd like to also highlight that we continue working very much with our technology partners. Fortum and GEA are there as well, our key partners building the blueprint of the Factory 02. This is also one of the key elements in order to have a factory clearly designed. When we have offtakes and funding, that this is helping, the final investment decision will happen.
Thank you, Rami. We have time for a couple of more questions. Ilkka, can Solein powder be heated or will the bacteria die?
Of course, it goes through a somewhat thorough downstream processing at our factory. There's whatever comes to heating. First of all, there's full pasteurization, homogenization, drying, and multiple other steps. So it's already somewhat stable and processed ingredient as such. But what we are seeing, for example, in the baked goods category, we are seeing that Solein can indeed replace some of the animal-based and plant-based ingredients in the applications, also through heating and providing certain value adds. So it is indeed kind of handling heat relatively well.
Thank you, Ilkka. A final question for Rami. Please estimate your moat from now on.
A great question. This could be other chapter to tell. But if I somehow repeat what I said, the big picture, we are the leading pioneering technology company platform where we have been building now the ecosystem around, because then we are much stronger to set these factories, not only one, two, but multiple factories. Demand is there.
Demand is there. There is no other gas fermentation company who have permission for the food, human food, any place in the earth. So we have Singapore, and then we have U.S., the authority to sell at the moment. We are actually all going for the non-crustal-led process at the moment as well. So we are the leading company there. This is a journey, clearly very positive to Europe as well. We have more than 200 patents that's protecting our process.
We have our own microbe as well, what we have not published either. It is in our hands. I see that this is absolutely key moat for us, together with our Solein product value propositions. If you think about, we have these two, whole processing platform, and then we have the product, which is excellent as well, taste, texture, and all the other value propositions. I am very confident with our moat. The future is bright for us.
Thank you, Rami. Thank you, Ilkka. This concludes our webcast today. Thank you everybody in the audience for joining, and see you next time. Have a great day.
Thank you.
Thank you.